舍曲林
文拉法辛
安慰剂
盐酸文拉法辛
重性抑郁障碍
内科学
萧条(经济学)
医学
心理学
麻醉
精神科
抗抑郁药
宏观经济学
病理
经济
替代医学
扁桃形结构
海马体
作者
Mohammad Amin Momeni‐Moghaddam,Malihe Farid,Mahboobeh Mehrabani Natanzi,Zohreh Khodaii,Rahim Badrfam,Atefeh Zandifar
出处
期刊:Current psychopharmacology
[Bentham Science Publishers]
日期:2021-08-15
卷期号:10 (3): 244-250
被引量:2
标识
DOI:10.2174/2211556010666210712185437
摘要
Background: Due to the possible effect of omega-3 fatty acids on reducing depressive symptoms, in this study, we investigated these effects in combination with other antidepressants. Methods: The study was a double-blind clinical trial on 100 patients with major depressive disorder who were divided into four groups of 25 each and treated with 50 mg daily sertraline plus placebo, 50 mg daily sertraline plus two grams Omega 3 daily, 75 mg daily venlafaxine plus placebo, and 75 mg daily venlafaxine plus 2 g Omega 3 daily for 6 weeks. Results: The mean Hamilton depression rating score of sertraline and venlafaxine plus omega-3 after treatment were 4.42 and 4.23 respectively versus sertraline and venlafaxine plus placebo 14.4 and 14.2 respectively (P value=0.0001). Conclusion: Omega-3 enhanced the clinical function of sertraline and venlafaxine to reduce the severity of depression. Adding omega-3 to either sertraline or venlafaxine does not have a comparative advantage over each other in terms of the improvement of severity of depressive symptoms.
科研通智能强力驱动
Strongly Powered by AbleSci AI